Heron's (HRTX) Post-Operative Pain Candidate Encourages
September 23, 2015 at 21:07 PM EDT
Heron Therapeutics, Inc. announced positive, top-line data from a phase II study on HTX-011 for the management of post-operative pain in patients undergoing bunionectomy, developed using Heron’s proprietary Biochronomer drug delivery technology.
